Spring direct naar de hoofdnavigatie of de inhoud

Frits Schut

Patent attorney

“No matter what accomplishments your business makes, IP protection of essential technologies is vital to stay ahead of the competition.”
Home / Experts / Frits Schut

Frits Schut

Frits Schut

  • Life Sciences
  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner

Frits Schut has been involved in patenting since 1995, when exploiting patented inventions of which he was a co-inventor in a biotech startup.

Frits studied biology at the universities of Utrecht, Amsterdam and obtained his PhD in microbiology from the university of Groningen.

More information about Frits

While performing part of his PhD work at the University of Alaska Fairbanks he came into contact with molecular genetics and DNA diagnostics. He was able to further develop these techniques for medical and veterinary application with the Medical faculty in Groningen and these developments were commercially implemented in a startup diagnostic company, of which he was a co-director.

Frits joined V.O. in 2001. He has broad expertise, and is particularly involved in therapeutic and diagnostic (medical) biotechnology, microbiology and plant protection. Both because of his background and portfolio, Frits has special experience with Life Science companies aiming to protect their essential technologies. He has a wide experience in patent cases before the European Patent Office and the Court of The Hague. Frits also has experience with plant protection before the Dutch and Community Plant Variety Office.

Working experience

  • Patent Attorney, V.O. (2001-present)
  • Co-Director and CSO Microscreen, Groningen (1995-2000)
  • Post-Doc, University of Groningen (1993)
  • Visiting Scientist, University of Alaska Fairbanks (1988)

Education

  • PhD in Microbiology, University of Groningen (1994)
  • MSc in Biology, University of Groningen (1988), Major in Microbiology

Professional & Community Activities

  • Member of UNION (Secretary of Life Sciences Commission)
  • Member of AIPLA
  • Member of FICPI
  • Member of Netherlands Institute of Patent Attorneys
  • Member of EPI

Languages

  • English
  • Dutch

Also see these experts

Jennifer Ebner von Eschenbach

  • European Patent Attorney
  • Senior Associate
Wezenbeek, Bart van

Bart van Wezenbeek

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts

News

IP Academy well attended

This year’s IP Academy was scheduled between 1 and 15 November and saw broad participation from all sectors of our Dutch client database.Continue reading

Plants can be patentable after all

Classically bred plants should be held patentable once again. Last Wednesday the EPO Board of Appeal came to this remarkable decision. On July 1st last year the EPO – on explicit advice by the European member states – introduced guidelines that seemed to definitely exclude plants obtained by an essentially biological process from patentability. But […]Continue reading

The Ocean Cleanup at work

After an extensive trial phase with a U-shaped tube system, The Ocean Cleanup has finally begun to sweep the ocean clean, under the charismatic leadership of Boyan Slat. This all took place under an intense media spotlight.Continue reading

Events

Innovation for Health

World Trade Center (WTC) Rotterdam, Beursplein, Rotterdam

Innovation for Health is the premier event for key players in Health & Life Sciences in the Netherlands and Belgium. It provides a unique opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and decision makers in Life Sciences & Health. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event